OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

Transmembrane Proteins

Items 1-50 of 343

Set Ascending Direction
  • SKU
    Name
    Tag
    Expression Host
    Size
    Price
    Delivery Time
  • CCR10 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CCR10-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CCR10-Nanodisc, Flag Tag on SDS-PAGE
    TP721585
    CCR10 Human Recombinant Protein, Synthetic Nanodisc
    Human CCR10 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • GPR75 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. WB analysis of Human GPR75-Nanodisc with anti-Flag monoclonal antibody at 1/5000 dilution, followed by Goat Anti-Rabbit IgG HRP at 1/5000 dilution

    Figure 2. WB analysis of Human GPR75-Nanodisc with anti-Flag monoclonal antibody at 1/5000 dilution, followed by Goat Anti-Rabbit IgG HRP at 1/5000 dilution
    TP721403
    GPR75 Human Recombinant Protein, Synthetic Nanodisc
    Human GPR75 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • MC4R Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human MC4R-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human MC4R-Nanodisc, Flag Tag on SDS-PAGE
    TP721489
    MC4R Human Recombinant Protein, Synthetic Nanodisc
    Human MC4R full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • GIPR Human Recombinant Protein, Synthetic Nanodisc

    Figure 1. Elisa plates were pre-coated with Flag Tag GIPR-Nanodisc (0.2μg/per well). Serial diluted anti-GIPR monoclonal antibody (TA421370) solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-GIPR monoclonal antibody binding with GIPR-Nanodisc is 862.5ng/ml.

    Figure 1. Elisa plates were pre-coated with Flag Tag GIPR-Nanodisc (0.2μg/per well). Serial diluted anti-GIPR monoclonal antibody (TA421370) solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-GIPR monoclonal antibody binding with GIPR-Nanodisc is 862.5ng/ml.
    TP721497
    GIPR Human Recombinant Protein, Synthetic Nanodisc
    Human GIPR full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CD63 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CD63-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CD63-Nanodisc, Flag Tag on SDS-PAGE
    TP721402
    CD63 Human Recombinant Protein, Synthetic Nanodisc
    Human CD63 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CD63 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CD63-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CD63-Nanodisc, Flag Tag on SDS-PAGE
    TP721402M
    CD63 Human Recombinant Protein, Synthetic Nanodisc
    Human CD63 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CLDN6 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CLDN6-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CLDN6-Nanodisc, Flag Tag on SDS-PAGE
    TP721382M
    CLDN6 Human Recombinant Protein, Synthetic Nanodisc
    Human CLDN6 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CLDN6 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of CLDN6 MNPs A. Negative Control 1: CLDN6 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CLDN6 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CLDN6 full length membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of CLDN6 MNPs A. Negative Control 1: CLDN6 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CLDN6 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CLDN6 full length membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721380M
    CLDN6 Human Recombinant Protein, Membrane Nanoparticle
    Human Claudin-6 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • GLP1R Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human GLP1R-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human GLP1R-Nanodisc, Flag Tag on SDS-PAGE
    TP721488
    GLP1R Human Recombinant Protein, Synthetic Nanodisc
    Human GLP1R full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • TLR9 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human TLR9-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human TLR9-Nanodisc, Flag Tag on SDS-PAGE
    TP721513
    TLR9 Human Recombinant Protein, Synthetic Nanodisc
    Human TLR9 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CD24 Human Recombinant Protein, Exosome

    Figure 2. Nanoparticle Tracking Analysis of CD24 exosomes

    Figure 2. Nanoparticle Tracking Analysis of CD24 exosomes
    TP721379
    CD24 Human Recombinant Protein, Exosome
    Human CD24 full length protein on exosome.
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • CD24 Human Recombinant Protein, Exosome

    Figure 2. Nanoparticle Tracking Analysis of CD24 exosomes

    Figure 2. Nanoparticle Tracking Analysis of CD24 exosomes
    TP721379M
    CD24 Human Recombinant Protein, Exosome
    Human CD24 full length protein on exosome.
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • GPRC5D Human Recombinant Protein, Exosome

    Figure 2. Nanoparticle Tracking Analysis of GPRC5D exosomes

    Figure 2. Nanoparticle Tracking Analysis of GPRC5D exosomes
    TP721384
    GPRC5D Human Recombinant Protein, Exosome
    Human GPRC5D full length protein on exosome.
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • GPRC5D Human Recombinant Protein, Exosome

    Figure 2. Nanoparticle Tracking Analysis of GPRC5D exosomes

    Figure 2. Nanoparticle Tracking Analysis of GPRC5D exosomes
    TP721384M
    GPRC5D Human Recombinant Protein, Exosome
    Human GPRC5D full length protein on exosome.
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • CLDN18.2 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CLDN18.2-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CLDN18.2-Nanodisc, Flag Tag on SDS-PAGE
    TP721388
    CLDN18.2 Human Recombinant Protein, Synthetic Nanodisc
    Human CLDN18.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CLDN18.2 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CLDN18.2-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CLDN18.2-Nanodisc, Flag Tag on SDS-PAGE
    TP721388M
    CLDN18.2 Human Recombinant Protein, Synthetic Nanodisc
    Human CLDN18.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CCR2 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CCR2-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CCR2-Nanodisc, Flag Tag on SDS-PAGE
    TP721400
    CCR2 Human Recombinant Protein, Synthetic Nanodisc
    Human CCR2 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CCR8 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. WB analysis of Human CCR8-Nanodisc with anti-CCR8 monoclonal antibody (TA421280) at 1μg/ml, followed by Goat Anti-Human IgG HRP at 1/5000 dilution

    Figure 2. WB analysis of Human CCR8-Nanodisc with anti-CCR8 monoclonal antibody (TA421280) at 1μg/ml, followed by Goat Anti-Human IgG HRP at 1/5000 dilution
    TP721409
    CCR8 Human Recombinant Protein, Synthetic Nanodisc
    Human CCR8 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CCR8 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. WB analysis of Human CCR8-Nanodisc with anti-CCR8 monoclonal antibody (TA421280) at 1μg/ml, followed by Goat Anti-Human IgG HRP at 1/5000 dilution

    Figure 2. WB analysis of Human CCR8-Nanodisc with anti-CCR8 monoclonal antibody (TA421280) at 1μg/ml, followed by Goat Anti-Human IgG HRP at 1/5000 dilution
    TP721409M
    CCR8 Human Recombinant Protein, Synthetic Nanodisc
    Human CCR8 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CD47 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CD47-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CD47-Nanodisc, Flag Tag on SDS-PAGE
    TP721411
    CD47 Human Recombinant Protein, Synthetic Nanodisc
    Human CD47 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CD47 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CD47-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CD47-Nanodisc, Flag Tag on SDS-PAGE
    TP721411M
    CD47 Human Recombinant Protein, Synthetic Nanodisc
    Human CD47 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CD37 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CD37-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CD37-Nanodisc, Flag Tag on SDS-PAGE
    TP721414
    CD37 Human Recombinant Protein, Synthetic Nanodisc
    Human CD37 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CD37 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CD37-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CD37-Nanodisc, Flag Tag on SDS-PAGE
    TP721414M
    CD37 Human Recombinant Protein, Synthetic Nanodisc
    Human CD37 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • SLC7A11 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human SLC7A11-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human SLC7A11-Nanodisc, Flag Tag on SDS-PAGE
    TP721420
    SLC7A11 Human Recombinant Protein, Synthetic Nanodisc
    Human SLC7A11 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • SLC7A11 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human SLC7A11-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human SLC7A11-Nanodisc, Flag Tag on SDS-PAGE
    TP721420M
    SLC7A11 Human Recombinant Protein, Synthetic Nanodisc
    Human SLC7A11 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • APLNR Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human APLNR-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human APLNR-Nanodisc, Flag Tag on SDS-PAGE
    TP721499
    APLNR Human Recombinant Protein, Synthetic Nanodisc
    Human APLNR full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • APLNR Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human APLNR-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human APLNR-Nanodisc, Flag Tag on SDS-PAGE
    TP721499M
    APLNR Human Recombinant Protein, Synthetic Nanodisc
    Human APLNR full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CCR8 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. Western blot of CCR8 MNPs

    Figure 2. Western blot of CCR8 MNPs
    TP721378M
    CCR8 Human Recombinant Protein, Membrane Nanoparticle
    Human CCR8 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • CCR8 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. Western blot of CCR8 MNPs

    Figure 2. Western blot of CCR8 MNPs
    TP721378
    CCR8 Human Recombinant Protein, Membrane Nanoparticle
    Human CCR8 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • CLDN6 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human CLDN6-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human CLDN6-Nanodisc, Flag Tag on SDS-PAGE
    TP721382
    CLDN6 Human Recombinant Protein, Synthetic Nanodisc
    Human CLDN6 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • CLDN6 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of CLDN6 MNPs A. Negative Control 1: CLDN6 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CLDN6 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CLDN6 full length membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of CLDN6 MNPs A. Negative Control 1: CLDN6 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CLDN6 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CLDN6 full length membrane nanoparticles samples were stained with anti-CLDN6 antibody (TA421264) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721380
    CLDN6 Human Recombinant Protein, Membrane Nanoparticle
    Human Claudin-6 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • CB1 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of CB1 MNPs A. Negative Control 1: CB1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CB1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CB1 full length membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of CB1 MNPs A. Negative Control 1: CB1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CB1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CB1 full length membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721383
    CB1 Human Recombinant Protein, Membrane Nanoparticle
    Human CB1 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • CB1 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of CB1 MNPs A. Negative Control 1: CB1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CB1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CB1 full length membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of CB1 MNPs A. Negative Control 1: CB1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CB1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CB1 full length membrane nanoparticles samples were stained with anti-CB1 antibody (BME100049) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721383M
    CB1 Human Recombinant Protein, Membrane Nanoparticle
    Human CB1 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • CLDN18.2 Human Recombinant Protein, Virus-like Particle

    Figure 2. FACS analysis of CLDN18.2 VLP A. Negative Control 1: CLDN18.2 VLP were stained only with Goat anti-human IgG Fc-PE secondary antibody. B. Negative Control 2: Control VLP were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar; IMAB362) at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. C. Negative Control 3: CLDN18.2 VLP were stained with anti-BCMA antibody（an irrelevant antibody）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. D. CLDN18.2 VLP were stained with anti-CLDN18.2 antibody（Zolbetuximab biosimilar; IMAB362）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody.

    Figure 2. FACS analysis of CLDN18.2 VLP A. Negative Control 1: CLDN18.2 VLP were stained only with Goat anti-human IgG Fc-PE secondary antibody. B. Negative Control 2: Control VLP were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar; IMAB362) at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. C. Negative Control 3: CLDN18.2 VLP were stained with anti-BCMA antibody（an irrelevant antibody）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. D. CLDN18.2 VLP were stained with anti-CLDN18.2 antibody（Zolbetuximab biosimilar; IMAB362）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody.
    TP721381M
    CLDN18.2 Human Recombinant Protein, Virus-like Particle
    Human Full length Claudin 18.
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • GPRC5D Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human GPRC5D-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human GPRC5D-Nanodisc, Flag Tag on SDS-PAGE
    TP721385
    GPRC5D Human Recombinant Protein, Synthetic Nanodisc
    Human GPRC5D full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • GPRC5D Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human GPRC5D-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human GPRC5D-Nanodisc, Flag Tag on SDS-PAGE
    TP721385M
    GPRC5D Human Recombinant Protein, Synthetic Nanodisc
    Human GPRC5D full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • SSTR2 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of SSTR2 MNPs A. Negative Control 1: SSTR2 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: SSTR2 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. SSTR2 full length membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of SSTR2 MNPs A. Negative Control 1: SSTR2 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: SSTR2 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. SSTR2 full length membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721386
    SSTR2 Human Recombinant Protein, Membrane Nanoparticle
    Human SSTR2 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • SSTR2 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of SSTR2 MNPs A. Negative Control 1: SSTR2 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: SSTR2 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. SSTR2 full length membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of SSTR2 MNPs A. Negative Control 1: SSTR2 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: SSTR2 full length membrane nanoparticles samples were stained with anti-GPRC5D antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. SSTR2 full length membrane nanoparticles samples were stained with anti-SSTR2 antibody (TA421285) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721386M
    SSTR2 Human Recombinant Protein, Membrane Nanoparticle
    Human SSTR2 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • SSTR2 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human SSTR2-Nanodisc, His/Flag Tag on SDS-PAGE

    Figure 2. Human SSTR2-Nanodisc, His/Flag Tag on SDS-PAGE
    TP721387
    SSTR2 Human Recombinant Protein, Synthetic Nanodisc
    Human SSTR2 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • SSTR2 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human SSTR2-Nanodisc, His/Flag Tag on SDS-PAGE

    Figure 2. Human SSTR2-Nanodisc, His/Flag Tag on SDS-PAGE
    TP721387M
    SSTR2 Human Recombinant Protein, Synthetic Nanodisc
    Human SSTR2 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • CLDN18.2 Human Recombinant Protein, Virus-like Particle

    Figure 2. FACS analysis of CLDN18.2 VLP A. Negative Control 1: CLDN18.2 VLP were stained only with Goat anti-human IgG Fc-PE secondary antibody. B. Negative Control 2: Control VLP were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar; IMAB362) at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. C. Negative Control 3: CLDN18.2 VLP were stained with anti-BCMA antibody（an irrelevant antibody）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. D. CLDN18.2 VLP were stained with anti-CLDN18.2 antibody（Zolbetuximab biosimilar; IMAB362）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody.

    Figure 2. FACS analysis of CLDN18.2 VLP A. Negative Control 1: CLDN18.2 VLP were stained only with Goat anti-human IgG Fc-PE secondary antibody. B. Negative Control 2: Control VLP were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar; IMAB362) at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. C. Negative Control 3: CLDN18.2 VLP were stained with anti-BCMA antibody（an irrelevant antibody）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. D. CLDN18.2 VLP were stained with anti-CLDN18.2 antibody（Zolbetuximab biosimilar; IMAB362）at 1μg/mL, followed by Goat anti-human IgG Fc-PE secondary antibody.
    TP721381
    CLDN18.2 Human Recombinant Protein, Virus-like Particle
    Human Full length Claudin 18.
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • CCR4 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of CCR4 MNPs A. Negative Control 1: CCR4 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CCR4 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CCR4 full length membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of CCR4 MNPs A. Negative Control 1: CCR4 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CCR4 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CCR4 full length membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721390M
    CCR4 Human Recombinant Protein, Membrane Nanoparticle
    Human CCR4 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • CCR4 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of CCR4 MNPs A. Negative Control 1: CCR4 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CCR4 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CCR4 full length membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of CCR4 MNPs A. Negative Control 1: CCR4 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: CCR4 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. CCR4 full length membrane nanoparticles samples were stained with anti-CCR4 antibody (TA421267) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721390
    CCR4 Human Recombinant Protein, Membrane Nanoparticle
    Human CCR4 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • ADORA2A Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of ADORA2A MNPs A. Negative Control 1: ADORA2A full length membrane nanoparticles samples were stained only with Goat anti-mouse lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. C. Negative Control 3: ADORA2A full length membrane nanoparticles samples were stained with anti-His antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. D. ADORA2A full length membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody.

    Figure 2. FACS analysis of ADORA2A MNPs A. Negative Control 1: ADORA2A full length membrane nanoparticles samples were stained only with Goat anti-mouse lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. C. Negative Control 3: ADORA2A full length membrane nanoparticles samples were stained with anti-His antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. D. ADORA2A full length membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody.
    TP721391
    ADORA2A Human Recombinant Protein, Membrane Nanoparticle
    Human ADORA2A full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • ADORA2A Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human ADORA2A-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human ADORA2A-Nanodisc, Flag Tag on SDS-PAGE
    TP721392
    ADORA2A Human Recombinant Protein, Synthetic Nanodisc
    Human ADORA2A full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*
  • ADORA2A Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of ADORA2A MNPs A. Negative Control 1: ADORA2A full length membrane nanoparticles samples were stained only with Goat anti-mouse lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. C. Negative Control 3: ADORA2A full length membrane nanoparticles samples were stained with anti-His antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. D. ADORA2A full length membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody.

    Figure 2. FACS analysis of ADORA2A MNPs A. Negative Control 1: ADORA2A full length membrane nanoparticles samples were stained only with Goat anti-mouse lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. C. Negative Control 3: ADORA2A full length membrane nanoparticles samples were stained with anti-His antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. D. ADORA2A full length membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2μg/mL, followed by Goat anti-mouse IgG 488 secondary antibody.
    TP721391M
    ADORA2A Human Recombinant Protein, Membrane Nanoparticle
    Human ADORA2A full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • ADORA2A Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human ADORA2A-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human ADORA2A-Nanodisc, Flag Tag on SDS-PAGE
    TP721392M
    ADORA2A Human Recombinant Protein, Synthetic Nanodisc
    Human ADORA2A full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    100 ug
    $11,515.00
    3 Weeks*
  • TM4SF1 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of TM4SF1 MNPs A. Negative Control 1: TM4SF1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: TM4SF1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. TM4SF1 full length membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of TM4SF1 MNPs A. Negative Control 1: TM4SF1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: TM4SF1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. TM4SF1 full length membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721393
    TM4SF1 Human Recombinant Protein, Membrane Nanoparticle
    Human TM4SF1 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    50 ug
    $1,825.00
    3 Weeks*
  • TM4SF1 Human Recombinant Protein, Membrane Nanoparticle

    Figure 2. FACS analysis of TM4SF1 MNPs A. Negative Control 1: TM4SF1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: TM4SF1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. TM4SF1 full length membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.

    Figure 2. FACS analysis of TM4SF1 MNPs A. Negative Control 1: TM4SF1 full length membrane nanoparticles samples were stained only with Goat anti-human lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. C. Negative Control 3: TM4SF1 full length membrane nanoparticles samples were stained with anti-CCR8 antibody (an irrelevant antibody) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody. D. TM4SF1 full length membrane nanoparticles samples were stained with anti-TM4SF1 antibody (TA421309) at 2μg/mL, followed by Goat anti-human IgG 488 secondary antibody.
    TP721393M
    TM4SF1 Human Recombinant Protein, Membrane Nanoparticle
    Human TM4SF1 full length protein membrane nanoparticles (MNPs).
    C-Flag Tag
    HEK293
    100 ug
    $2,395.00
    3 Weeks*
  • TM4SF1 Human Recombinant Protein, Synthetic Nanodisc

    Figure 2. Human TM4SF1-Nanodisc, Flag Tag on SDS-PAGE

    Figure 2. Human TM4SF1-Nanodisc, Flag Tag on SDS-PAGE
    TP721394
    TM4SF1 Human Recombinant Protein, Synthetic Nanodisc
    Human TM4SF1 full length protein-synthetic nanodisc.
    C-Flag Tag
    HEK293
    10 ug
    $1,395.00
    3 Weeks*

Items 1-50 of 343